Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979
Report date:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Deviations:
yes
Remarks:
lack of details on test method
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
N-methyl-N-[C18-(unsaturated)alkanoyl]glycine
EC Number:
701-177-3
Molecular formula:
C21H39NO3
IUPAC Name:
N-methyl-N-[C18-(unsaturated)alkanoyl]glycine

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: WIGA, Sulzfeld, Germany
- Weight at study initiation: 187 g (males), 204 g (females)
- Diet: Herilan MRH (Eggersmann KG, Rinteln/Weser, Germany), ad libitum
- Water: tap water, ad libitum

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose/head only
Vehicle:
not specified
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: dynamic head-nose apparatus (BUNDSCHUH, Griesheim, Germany) and constant infusion apperatus (UNITA I, BRAUN, Melsungen, Germany)
- Rate of air: 1000 L/h

TEST ATMOSPHERE
- Brief description of analytical method used: for the quantitative analysis an indirect indicator method was used. Therefore, the substance was mixed with 0.06 and 0.19% Oil Res 0 C.J. 26125. The samples were measured spectroscopically at 525 nm and the concentration of the test substance was evaluated using a calibration line.
- Samples taken from breathing zone: yes
Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
4 h
Concentrations:
0.3, 0.6, 2.2 and 3.7 mg/L (analytical concentration)
0.95, 1.67, 11.4 and 22.7 mg/L (nominal concentration)
No. of animals per sex per dose:
10
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: animals were observed daily for mortality and individual body weights were determined before start of the study and thereafter weekly
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
The statistical analysis was performed according to the "Probitanalyse" (D.J. Finney, 1971, Syndics of the Cambridge University Press, London, UK).

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
male/female
Dose descriptor:
LC50
Effect level:
1.37 mg/L air (analytical)
Based on:
test mat.
Exp. duration:
4 h
Sex:
female
Dose descriptor:
LC50
Effect level:
1.8 mg/L air (analytical)
Based on:
test mat.
Exp. duration:
4 h
Sex:
male
Dose descriptor:
LC50
Effect level:
ca. 1.05 mg/L air (analytical)
Based on:
test mat.
Exp. duration:
4 h
Mortality:
0.6 mg/L: 3 males and 1 female animal died
2.2 mg/L: 10 males and 4 females died
3.7 mg/L: 8 males and 10 females died
Clinical signs:
other: 0.3 mg/L: flight attempts and gasping breathing 0.6 mg/L: additional to the signs of the low dose group and noisy breathing and slight staggering. One female showed lateral position. 2.2 mg/L: additional to the signs of the 0.6 mg/L dose group and bloody
Body weight:
2.2 mg/L (females): weight loss (mean 8 g) from Day 7-14
3.7 mg/L (males): weight loss (mean 4 g) from the Day of exposure to Day 7
Gross pathology:
Animals that died during the study period:
0.6 mg/L: heart: acute dilatation, acute hyperemia; lung: oedema with emphysema at the edges, pulmonary lobes were wet and fleshy and excess of blood were observed
2.2 mg/L: acute dilatation, acute hyperemia; lung: severe exhalation especially at the peripheral areas, severe oedema formation, single areas wet and fleshy. One animal with slight hydrothorax
3.7 mg/L: acute dilatation, acute hyperemia; lung: laminar bleedings, slight exhalation

Surviving animals:
Organs showed no signs of toxicity.

Any other information on results incl. tables

Table 1. Table for acute inhalation toxicity.

Target concentration
[mg/L air]

Toxicological results*

Duration of clinical signs

Mortality (%)

Males

0.3

0/10/10

Day 2-7

0

0.6

3/10/10

Day 2-7

30

2.2

10/10/10

Day 2-7

100

3.7

8/10/10

Day 2-7

80

Females

0.3

0/10/10

Day 2-7

0

0.6

1/10/10

Day 2-7

10

2.2

4/10/10

Day 2-7

40

3.7

10/10/10

Day 2-7

100

LC50 = 1.37 (1.01-1.85) mg/L air

* first number = number of dead animals

 second number = number of animals with clinical signs

 third number = number of animals used

Applicant's summary and conclusion

Interpretation of results:
other: Acute tox. Inhalation 4, H332. Classification according to Regulation (EC) No. 1272/2008 (CLP/EU GHS).